Hodgkin's disease and Epstein-Barr virus;Le role du virus d'Epstein-Barr

Presse Medicale

Volumn 26, Issue 23, 1997, Pages 1104-1106

  Brousset, P ^a   Delsol, G ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; VIRUS PROTEIN;

ADULT; EPSTEIN BARR VIRUS; FEMALE; GENETIC POLYMORPHISM; HODGKIN DISEASE; HUMAN; IN SITU HYBRIDIZATION; INFANT; MALE; NASOPHARYNX CANCER; REED STERNBERG CELL; REVIEW; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PHYSIOLOGY; VIROLOGY;

HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IN SITU HYBRIDIZATION;

EID: 0031554571     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. e edit. Epstein-Barr virus and its replication in Fields BN, Knipe DM (eds): Virology, Raven, New York, 1990 : 1889.
2. Brousset P, Meggetto F, Knecht H, Schlaifer D, Mariamé B, Selves J, Delsol C. Implication du virus d'Epstein-Barr dans la maladie de Hodgkin. Hématologie 1995 ; 1:219-26.
3. Selves J, Bibeau F, Brousset P et al. Epstein-Barr virus latent and replicative gene expression in gastric carcinoma. Histopathology 1996 ; 28:121-7.
4. Mueller N, Evans A, Harris N et al. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 1989 ; 320:689-95.
5. Brousset P, Meggetto F, Chittal S et al. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease. Lab Invest 1993 ; 69:483-90.
6. Knecht H, Bachmann E, Brousset P et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993 ; 82:2937-42.
7. Brousset P, Schlaifer D, Meggetto F et al. Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease. Blood 1994 ; 84:2447-51.
8. Vassef MA Kamel OW, Chen YY, Medeiros LJ, Weiss LM. 1995. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Pathol 1995 ; 147:1408-15.
9. Roux M, Schraven B, Roux A, Gamm H, Mertelsmann R, Meuer S. Natural inhibitors of T-cell activation in Hodgkin's disease. Blood 1991 ; 78:2365-71.
10. Renner C, Ohnesorge S, Held G et al. T cells patients with Hodgkin's disease have a defective T-cell receptor ζ chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood 1996 ; 88:236-41.
11. Frisan T, Sjöberg J, Dolcetti R et al. Local suppression of Epstein-Barr (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 1995 ; 86:1493-1501.
12. Meggetto F, Brousset P, Selves J, Delsol G, Mariamé B. Reed-Sternberg cells and "bystander" lymphocytes in lymph nodes involved by Hodgkin's disease are infected with different strains of Epstein-Barr virus (EBV). J Virol 1997 ; 71:2547-9.